Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: January 27th 2025 | Updated: January 28th 2025
Patient-Centered Care in Myelofibrosis: Managing Expectations and Quality-of-Life Outcomes
Published: January 27th 2025 | Updated: January 28th 2025
Myelofibrosis Disease Biology: From Molecular Mechanisms to Clinical Phenotypes and Therapeutic Targets
Published: January 26th 2022 | Updated: January 28th 2025
Part 1: Selecting Treatment Options for Relapsed/Refractory Multiple Myeloma
Published: June 20th 2022 | Updated: January 28th 2025
Considering Alternatives to CAR T-Cell Therapy for Primary Refractory DLBCL